Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter CXohort Study

Chan-Young Kim

Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter CXohort Study

Chan-Young Kim

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Journal of Gastric Cancer
State	Published - 2022.03.8

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{8fb8b699c33a4087b90ba95920ce9f14,

title = "Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter CXohort Study",

author = "Chan-Young Kim",

year = "2022",

month = mar,

day = "8",

language = "Korean",

journal = "Journal of Gastric Cancer",

issn = "2093-582X",

}